Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Smith & Nephew SNATS, Inc. (SNN : NYSE)
 
 • Company Description   
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Number of Employees: 17,349

 
 • Price / Volume Information   
Yesterday's Closing Price: $29.77 Daily Weekly Monthly
20 Day Moving Average: 854,436 shares
Shares Outstanding: 437.97 (millions)
Market Capitalization: $13,038.45 (millions)
Beta: 0.69
52 Week High: $31.72
52 Week Low: $23.69
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.96% -3.93%
12 Week 14.37% -0.86%
Year To Date 21.11% 14.42%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
BUILDING 5 CROXLEY PARK HATTERS LANE
-
WATFORD,X0 WD18 8YE
GBR		 ph: 44-19-2347-7340
fax: 44-20-7930-3353		 investorrelations.global@smith-nephew.com http://www.smith-nephew.com
 
 • General Corporate Information   
Officers
Deepak Nath - Chief Executive Officer
Rupert Soames - Chairman
John Rogers - Chief Financial Officer
Bob White - Independent Non-Executive Director
Rick Medlock - Independent Non-Executive Director

Peer Information
Smith & Nephew SNATS, Inc. (BJCT)
Smith & Nephew SNATS, Inc. (CADMQ)
Smith & Nephew SNATS, Inc. (APNO)
Smith & Nephew SNATS, Inc. (UPDC)
Smith & Nephew SNATS, Inc. (IMTIQ)
Smith & Nephew SNATS, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 83175M205
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 437.97
Most Recent Split Date: 10.00 (2.50:1)
Beta: 0.69
Market Capitalization: $13,038.45 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 3.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.89
Current Fiscal Year EPS Consensus Estimate: $1.96 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 16.57% Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 15.17
Trailing 12 Months: -
PEG Ratio: 0.92
Price Ratios
Price/Book: 2.47
Price/Cash Flow: 9.43
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 2.89
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 1.33
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - 8.57
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - 12.04
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - 0.72
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - 0.62
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - 38.23
 

Powered by Zacks Investment Research ©